Molson Coors Beverage Company reported Q4 and full year 2025 financial results with net sales declines and GAAP net loss for the year due to impairment charges, alongside Q4 underlying EPS of $1.21. The Board approved a $2.0 billion increase to the Class B common stock repurchase program, bringing total authorization to $4.0 billion through December 31, 2031, with $2.6 billion remaining as of December 31, 2025.
Key takeaways
Q4 2025 net sales $2,662.4 million, down 2.7% reported / 4.0% constant currency
Q4 2025 GAAP income before income taxes $266.3 million, down 23.1%; underlying $296.8 million, down 13.8% constant currency
Full year 2025 GAAP net loss attributable to MCBC $2,139.6 million ($10.75 per diluted share); underlying diluted EPS $5.42, down 9.1%
Full year 2025 net cash provided by operating activities $1,784.4 million; underlying free cash flow $1,141.4 million
Share repurchase program increased by $2.0 billion to $4.0 billion total authorization, extended to December 31, 2031; $2.6 billion remaining as of December 31, 2025
2026 guidance: net sales revenue growth flat +/-1% constant currency; underlying pretax income -15% to -18% decline constant currency